Norges Bank’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
JT
RCM
DTC
Norges Bank's PCVX Position: Q2 2026 in Review
Norges Bank opened a new position in Vaxcyte (PCVX) in Q2 2026: 1,245,805 shares worth $72.4M. The stake represents 0.01% of the portfolio and ranks #893 among its holdings. This is a return to the name: Norges Bank previously reported a position in PCVX as recently as Q4 2025.
Norges Bank first reported a position in PCVX in Q2 2020 and has held it in 16 quarters since. The position peaked at $127M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- Norges Bank held 1,245,805 shares of Vaxcyte worth $72.4M as of Q2 2026.
- Vaxcyte was a new Norges Bank position in Q2 2026.
- Vaxcyte made up 0.01% of Norges Bank's portfolio in Q2 2026, its #893 holding.
- Norges Bank first reported a position in Vaxcyte in Q2 2020 and has held it in 16 quarters since.
- Norges Bank's Vaxcyte position peaked at $127M in Q3 2024.
- 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.